The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

FDA-approved semaglutide drug is the first GLP-1 pill for weight loss available in the U.S., according to drugmaker Novo ...

The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

The new oral drug costs as little as $149 a month out of pocket and is expected to broaden access as demand for GLP-1 ...

The FDA-approved weight loss drug offers an oral alternative to invasive injections with similar effectiveness.

Danish drugmaker Novo Nordisk said the first-of-its kind oral pill will offer 1.5 and 4 milligram doses at $149 per month for ...

First and only GLP-1 pill on the market costs significantly less than injectable versions ...

Pharmaceutical company Novo Nordisk announced that a new pill-version of its GLP-1 weight-loss drug is now "broadly available ...

Manufacturer Novo Nordisk has partnered with telehealth companies and other weight-loss groups to increase access to the pill ...

Novo Nordisk has launched the first once-daily oral version of Wegovy, marking the arrival of the first GLP-1 weight-loss ...

Novo Nordisk's Wegovy, the first oral GLP-1 weight-loss pill, is now in 70,000+ US pharmacies, costing $5 (£4) to $10 (£7) ...

Novo Nordisk is the first manufacturer to market its drug Wegovy in pill form in the U.S., though Eli Lilly expects approval ...